Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

Compositions and methods of treating muscular dystrophy with thromboxane-A2 receptor antagonists

US Patent 10064845 · Granted Sep 4, 2018

Estimated economic value: $721,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of treating cardiac fibrosis with ifetroban2024
Compositions and methods of treating cardiac fibrosis with ifetroban2024
Compositions and methods of treating cardiac fibrosis with ifetroban2024
Injectable ibuprofen formulation2023
Compounds and methods for scavenging dicarbonyl electrophiles2023
Thromboxane receptor antagonists in AERD/asthma2023
Compositions and methods of treating cardiac fibrosis with ifetroban2021
Compositions and methods of treating cardiac fibrosis with ifetroban2021
Compositions and methods of treating cardiac fibrosis with ifetroban2021
Compositions and methods of treating cardiac fibrosis with ifetroban2020
Compositions and methods of treating cardiac fibrosis with ifetroban2020
Compositions and methods of treating cardiac fibrosis with ifetroban2020